KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Announces Distribution Agreement with 3D-Side

OrthoPediatrics Corp. Announces Distribution Agreement with 3D-Side

OrthoPediatrics to Provide Preoperative Planning Software and Patient Specific Solution for Pediatric Orthopedic Surgeons with State-of-the-Art, Osteotomy and Tumor Resection Cutting Guides

WARSAW, Ind., July 13, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with 3D-Side S.A., a Belgium based software developer and manufacturer of patient specific 3D printed cutting guides. This commercial agreement grants OrthoPediatrics exclusive distribution rights of the 3D-CUT-OSTEO osteotomy guide in the United States’ leading pediatric hospitals in addition to certain international markets in the future.

3D-CUT patient specific guides, designed from CT or MRI images, assist surgeons performing corrective and bone tumor resection osteotomies. The single use guide technology enables accurate deformity or tumor corrective procedures.

OrthoPediatrics’ President and CEO David Bailey commented, “the 3D-Side technology complements the OrthoPediatrics’ pediatric limb deformity implant and biologic offering, and increases exposure in the pediatric oncology market, where many of the most challenging orthopedic cases involving tumor resection require a full complement of solutions including implants, biologics, and patient specific devices. We are excited to enter this relationship with 3D-Side to provide our pediatric orthopedic customers access to the 3D-CUT products.”

3D-Side Co-CEO, Laurent Paul stated, "Our partnership with OrthoPediatrics is based on a shared mission and commitment to limit the risks involved in surgery on medically challenged young patients. Because each patient is unique, we imagine dedicated solutions to fit their surgical needs. Thanks to the OrthoPediatrics partnership, we are thrilled to expand these well-established products in Europe to the USA and bring our expertise to pediatric orthopedic surgeons in the United States," said Laurent Paul, 3D-Side's Co-CEO.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 37 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 45 countries outside the United States. For more information, please visit

About 3D-Side, S.A.

3D-Side is a Belgian company having developed first class products in cranioplasty, bone tumor surgery and deformity correction for more than 10 years. Its mission is to offer patient specific medical devices to allow planning of complex surgeries with incomparable quality. Based on this internal know-how, 3D-Side has developed a very specific vision on integrated surgical software and technologies. Through this vision, an innovative platform named Customize developed, connecting surgeons, patients, and medical device companies to optimize and streamline communication, creation and production of patient-specific medical devices. Personalization is in our DNA. We believe a tailor-made solution for each unique patient is key to, together with the surgeons, make surgeries a moment of confidence and persevere against risks. Ensuring that life wins in the end is at the heart of what we do. We are believers of 'together we are stronger’.

Investor Contacts

Matt Bacso, CFA

Gilmartin Group



EN
13/07/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annu...

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including...

 PRESS RELEASE

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and...

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance First Quarter 2025 Revenue Increased 17% Year-over-Year WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ ...

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company’s 5th FDA approval in 2025. 3P Pediatric Plating Platform Hip System is a new plate and scre...

 PRESS RELEASE

OrthoPediatrics Corp. to Report First Quarter Financial Results on May...

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025 WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of Verte...

OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company’s 80th system designed to treat musculoskeletal issues in children. VerteGlide is a guided growth technology designed for children with Early Onset S...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch